Glenn C. David — Chief Financial Officer and Executive Vice President at Zoetis

Mr. Glenn David has been the Chief Financial Officer and Executive Vice President of Zoetis Inc. since August 19, 2016. Mr. David served as Senior Vice President of Finance Operations at Zoetis Inc. from April 22, 2014 to September 1, 2014. Mr. David served as an Acting Chief Financial Officer of Zoetis Inc. from April 22, 2014 to September 1, 2014. He has more than 20 years of experience in finance and operations -- including roles at Pfizer, Bankers Trust, Paine Webber and Credit Suisse. Mr. David has played a key role in leading the financial operations for Zoetis since its Initial Public Offering (IPO), including financial planning, analysis and support across its 70 global markets. Most recently, Mr. David has served as Senior Vice President of Finance Operations for Zoetis, where he had led a team of more than 300 finance professionals and played a critical role in the company's preparation and execution of its IPO in 2013. Before the Zoetis IPO, Mr. David enjoyed a career in Finance at its former parent company, Pfizer. He served in various financial roles at Pfizer, including vice president of Global Finance for Pfizer Animal Health and vice president of Finance for the U.S. Primary Care franchise. Mr. David also played important financial roles in Pfizer's integrations of the Pharmacia, Wyeth and King Pharmaceuticals' acquisitions. Prior to joining Pfizer in 1999, Mr. David gained valuable financial experience at Bankers Trust, Paine Webber and Credit Suisse. He graduated magna cum laude with a Bachelor's degree in Finance from Binghamton University and earned his MBA in Finance/Information Technology from New York University.